New omicron subvariants are rising in U.S. and FDA panel gives its backing to Novavax vaccine

The BA.4 and BA.5 subvariants of the highly transmissible omicron variant of the coronavirus that causes COVID-19 are spreading rapidly, according to data from the Centers for Disease Control and Prevention, and may overtake others to dominate in the U.S.